Topical Corticosteroids Market Revenue, Company Growing Demand and Regional Outlook Up To 2027

-
Topical Corticosteroids Market
Topical Corticosteroids Market

Topical corticosteroids are a class of medications that are commonly used to treat skin inflammation and other related conditions. These medications are available in various forms such as creams, ointments, lotions, gels, and solutions. Topical corticosteroids work by reducing inflammation and swelling in the affected areas of the skin, thus providing relief to patients suffering from skin-related ailments. The global Topical Corticosteroids Market is expected to grow significantly over the next few years, owing to the growing demand for these medications.

Market Revenue and Forecast

The global Topical Corticosteroids Market is expected to reach a value of USD 4,821.2 million by 2023, growing at a CAGR of 5.8% during the forecast period (2017-2023).

The growing prevalence of skin diseases such as eczema, psoriasis, and dermatitis, coupled with the increasing geriatric population, is driving the demand for topical corticosteroids. Moreover, the availability of several types of topical corticosteroids and the increasing awareness about their benefits are expected to drive market growth during the forecast period.

Company Growing Demand

The topical corticosteroids for market is highly competitive, with several major players operating in the industry. These companies are focused on expanding their product portfolios and strengthening their presence in the global market. Some of the leading companies in the topical corticosteroids for market include Pfizer Inc., Novartis AG, Merck & Co. Inc., GlaxoSmithKline Plc., Sanofi S.A., and others.

The global topical corticosteroids for market, with a wide range of products such as Eucrisa, which is used to treat eczema. The company is focused on expanding its product portfolio and strengthening its presence in the market. In 2018, Pfizer Inc. acquired Array BioPharma, a biopharmaceutical company that specializes in the development of cancer treatments. The acquisition is expected to enhance Pfizer’s oncology portfolio and strengthen its position in the global market.

Novartis AG is another major player in the global Topical Corticosteroids Market, with a range of products such as Elidel and Xolair. The company is focused on expanding its product portfolio and increasing its market share in the global market. In 2018, Novartis AG acquired AveXis, a gene therapy company, for USD 8.7 billion. The acquisition is expected to strengthen Novartis’ position in the gene therapy market and enhance its product portfolio.

Comments

Post a Comment

Popular posts from this blog

Intravenous Fluid Therapy is the Fastest Growing Segment Fueling the Growth of Intravenous Solutions Market

-
Image
Intravenous Solutions Market The global Intravenous Solutions Market is estimated to be valued at US$ 577,228 bn or Million in 2023 and is expected to exhibit a CAGR of 6.1% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights. Market Overview: Intravenous solutions are fluids administered through a vein via a needle or catheter. They are often used to provide essential nutrients, medications, or fluids to patients. Common uses include rehydration, correcting electrolyte imbalances, and ensuring nutrition is delivered for patients who cannot eat or absorb nutrients through the digestive system. Market key trends: One of the major trends in the intravenous solutions market is the increasing use of intravenous fluid therapy. Intravenous fluid therapy involves the administration of aqueous solutions containing electrolytes, sugars, and medications through an intravenous catheter. It is widely used for rehydration, maintenance of f...
Read more

Endometrial Ablation Market Analysis, Industry Scope, Global Opportunity Analysis and Forecast Till 2027

-
Image
Endometrial Ablation Market Endometrial ablation is a procedure used to treat abnormally high uterine bleeding that cannot be managed by medicine by facilitating the destruction of the endometrium, a thin layer of the uterine wall. According to the American College of Obstetrics and Gynecology, Endometrial Ablation Market is not indicated for women who have endometrial diseases, endometrial hyperplasia, uterine cancer, a recent pregnancy, and specific uterine infections (ACOG). There are various endometrial ablation procedures available, including radiofrequency, heated fluid, heated balloon, electrosurgery, freezing, and microwave ablation techniques, depending on the technique and kind of patient being treated. The easy access to recently developed sophisticated ablation technology, convenience of use, shorter treatment times, and outpatient facilities, North America dominates the Endometrial Ablation Market . Endometrial ablation devices would see a sharp rise in global adoption d...
Read more

Blowing Agents Market Top Companies, Trends & Growth Factors, and Trend Forecast to 2025

-
Image
Blowing Agents Market The Blowing Agents Market is experiencing substantial growth, driven by the expanding demand from various industries such as construction, automotive, and packaging. Blowing agents are essential in foam production processes, contributing to lightweight and energy-efficient materials. Key market players are continuously investing in research and development to introduce eco-friendly and efficient blowing agents. The rising awareness regarding environmental concerns has led to the adoption of low global warming potential (GWP) and zero ozone depletion potential (ODP) blowing agents. Additionally, stringent regulations and policies promoting sustainable manufacturing practices have further accelerated the demand for environmentally friendly blowing agents. The market is witnessing a trend toward the adoption of innovative technologies to improve production efficiency and product performance. Advanced nucleating agents and microcellular foaming technologies are enhan...
Read more